5 Key Takeaways

• 1

  Patients using the estradiol acetate vaginal ring often experienced a loss of symptom control before the intended 90-day duration.

• 2

  Most patients reported a return of vasomotor symptoms during the final weeks of using the estradiol acetate vaginal ring.

• 3

  Seventeen patients supplemented therapy with an estrogen patch or gel in the last 2 to 4 weeks of ring use.

• 4

  The study involved a qualitative chart review of 31 patients from a single private practice regarding their experiences.

• 5

  Inconsistent documentation of serum estradiol levels limited the correlation between pharmacokinetics and clinical symptoms.